Opportunity Information: Apply for 72062020RFA00009

Water Resources Management for Enhanced Water, Sanitation, and Hygiene (WRM-WASH) is a USAID/Nigeria (USAID-Abuja) funding opportunity focused on improving water resources management in ways that strengthen water, sanitation, and hygiene outcomes. The opportunity is issued as a Round 6 call for concept papers under the New Partnerships Initiative Global Health Annual Program Statement (NPI GH APS) (APS No. 7200AA19APS00013). In practical terms, this means USAID is looking for short, early-stage concept submissions first, with the intent to identify promising ideas and partners that can later be developed into more complete applications or awards, depending on the pathway used.

The funding is posted under Funding Opportunity Number 72062020RFA00009 and is categorized as a continuation opportunity, using an “Other” type funding instrument, with the activity area listed as Health (CFDA 98.001). Even though WASH is often treated as an infrastructure or environment topic, USAID is explicitly positioning this call within a global health partnership framework, which signals an emphasis on public health impact, service reliability, and sustainability rather than only construction or hardware. The eligible applicant field is broad (“Others”), but the design of the call makes it clear the priority is to bring in partners that USAID considers new, underutilized, and local to the countries where they will work.

A central feature of this opportunity is that it sits under multiple “modalities” meant to widen participation beyond the usual large implementers. Modality 1 supports direct awards to new and underutilized organizations that are local entities in the host country or countries where they are applying. Modality 2 supports direct awards to new and underutilized organizations that qualify as locally established partners (LEPs) in the host country or countries. Modality 3 is structured for sub-awards to local new or underutilized partners, where a prime awardee plays a limited mentorship role rather than controlling implementation in the traditional way. Two sub-tracks are included under Modality 3: 3a for local entity sub-awardees that are moving toward becoming direct award recipients, and 3b for locally established partner sub-awardees. Modality 4 supports direct awards to partners specifically to leverage private or non-USAID funding, which is essentially encouraging cost-sharing, blended finance, or partnerships that bring additional resources to WASH and water resources management objectives.

In terms of scale, the award ceiling listed is up to $10,000,000. The posting also indicates an original closing date of November 2, 2020, and a creation date of September 23, 2020. While the number of expected awards is not specified in the provided data, the relatively high ceiling suggests USAID anticipated funding one or more substantial activities, or potentially a smaller set of larger awards depending on the strength of concepts received and how USAID chose to structure agreements under the APS framework.

Overall, WRM-WASH is best read as a partnership-driven USAID/Nigeria call that aims to expand the pool of implementing organizations, particularly local and underutilized groups, while advancing water resources management approaches that improve WASH outcomes. It combines public health framing with water systems and resource management priorities, and it offers multiple entry routes ranging from direct local awards to mentored sub-awards and arrangements that mobilize additional non-USAID capital.

  • The Nigeria USAID-Abuja in the health sector is offering a public funding opportunity titled "Water Resources Management for Enhanced Water, Sanitation, and Hygiene (WRM-WASH)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
  • This funding opportunity was created on 2020-09-23.
  • Applicants must submit their applications by 2020-11-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $10,000,000.00 in funding.
  • Eligible applicants include: Others.
Apply for 72062020RFA00009

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: Nigeria USAID-Abuja

Browse more opportunities from the same category: Health

Next opportunity: Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)

Previous opportunity: NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed).

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for 72062020RFA00009

 

Applicants also applied for:

Applicants who have applied for this opportunity (72062020RFA00009) also looked into and applied for these:

Funding Opportunity
Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed) Apply for RFA DC 20 002

Funding Number: RFA DC 20 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $499,999
Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed) Apply for RFA AI 20 055

Funding Number: RFA AI 20 055
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed) Apply for RFA AI 20 060

Funding Number: RFA AI 20 060
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed) Apply for RFA AI 20 057

Funding Number: RFA AI 20 057
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) Apply for PAR 21 027

Funding Number: PAR 21 027
Agency: National Institutes of Health
Category: Health
Funding Amount: $480,000
A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed) Apply for RFA AI 20 064

Funding Number: RFA AI 20 064
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) Apply for PAR 20 307

Funding Number: PAR 20 307
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed) Apply for RFA AI 20 056

Funding Number: RFA AI 20 056
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) Apply for PAR 20 308

Funding Number: PAR 20 308
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional) Apply for PAR 20 306

Funding Number: PAR 20 306
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
From Genomic Association to Causation: A Convergent Neuroscience Approach to Linking Levels of Analysis for Understanding Neuropsychiatric Disorders (U19 Clinical Trial Optional) Apply for RFA MH 21 165

Funding Number: RFA MH 21 165
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) Apply for PAR 21 032

Funding Number: PAR 21 032
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) Apply for RFA AI 20 076

Funding Number: RFA AI 20 076
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) Apply for PAR 21 037

Funding Number: PAR 21 037
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) Apply for PAR 21 055

Funding Number: PAR 21 055
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) Apply for PAR 21 054

Funding Number: PAR 21 054
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Improving Health Status and Human Capital in Senegal Apply for 72068521APS00001

Funding Number: 72068521APS00001
Agency: Senegal USAID-Dakar
Category: Health
Funding Amount: $88,000,000
NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (R25 - Clinical Trial Not Allowed) Apply for PAR 20 311

Funding Number: PAR 20 311
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) Apply for PAR 21 040

Funding Number: PAR 21 040
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Treatments for Lewy Body Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) Apply for RFA NS 21 008

Funding Number: RFA NS 21 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "72062020RFA00009", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: